ScoreWhy is MedCap AB ?
1
High Management Efficiency with a high ROE of 14.67%
2
The company is Net-Debt Free
3
Healthy long term growth as Operating profit has grown by an annual rate 30.65%
4
Positive results in Jun 26
- OPERATING CASH FLOW(Y) Highest at SEK 387.3 MM
- RAW MATERIAL COST(Y) Fallen by -1.35% (YoY)
- CASH AND EQV(HY) Highest at SEK 680.7 MM
5
With ROE of 15.00%, it has a attractive valuation with a 5.24 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -20.33%, its profits have risen by 10.4% ; the PEG ratio of the company is 3.7
6
Underperformed the market in the last 1 year
- Even though the market (OMX Stockholm 30) has generated returns of 27.70% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -20.33% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to MedCap AB should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is MedCap AB for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
MedCap AB
-20.33%
-0.12
36.44%
OMX Stockholm 30
27.7%
1.79
15.50%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
20.86%
EBIT Growth (5y)
30.65%
EBIT to Interest (avg)
10.33
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.16
Sales to Capital Employed (avg)
1.30
Tax Ratio
23.27%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.15%
ROE (avg)
14.67%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
35
Industry P/E
Price to Book Value
5.24
EV to EBIT
25.44
EV to EBITDA
16.59
EV to Capital Employed
5.65
EV to Sales
3.62
PEG Ratio
3.65
Dividend Yield
NA
ROCE (Latest)
22.20%
ROE (Latest)
15.00%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SEK 387.3 MM
RAW MATERIAL COST(Y)
Fallen by -1.35% (YoY
CASH AND EQV(HY)
Highest at SEK 680.7 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 6.46 times
NET SALES(Q)
Highest at SEK 606.3 MM
OPERATING PROFIT(Q)
Highest at SEK 138.3 MM
OPERATING PROFIT MARGIN(Q)
Highest at 22.81 %
PRE-TAX PROFIT(Q)
Highest at SEK 89.8 MM
NET PROFIT(Q)
Highest at SEK 69.1 MM
EPS(Q)
Highest at SEK 4.61
-7What is not working for the Company
INTEREST(HY)
At SEK 26.9 MM has Grown at 133.91%
DEBT-EQUITY RATIO
(HY)
Highest at 10.8 %
Here's what is working for MedCap AB
Operating Cash Flow
Highest at SEK 387.3 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SEK MM)
Net Sales
Highest at SEK 606.3 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (SEK MM)
Operating Profit
Highest at SEK 138.3 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (SEK MM)
Operating Profit Margin
Highest at 22.81 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at SEK 89.8 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (SEK MM)
Net Profit
Highest at SEK 69.1 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (SEK MM)
EPS
Highest at SEK 4.61
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (SEK)
Cash and Eqv
Highest at SEK 680.7 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 6.46 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -1.35% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for MedCap AB
Interest
At SEK 26.9 MM has Grown at 133.91%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Debt-Equity Ratio
Highest at 10.8 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
